Karen Prange is Director of ViewRay, Inc.. Currently has a direct ownership of 8,799 shares of VRAY, which is worth approximately $87. The most recent transaction as insider was on Jul 21, 2023, when has been sold 37,600 shares (Common Stock) at a price of $0.05 per share, resulting in proceeds of $1,880. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.8K
0% 3M change
0% 12M change
Total Value Held $87

Karen Prange Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 21 2023
SELL
Open market or private sale
$1,880 $0.05 p/Share
37,600 Reduced 81.04%
8,799 Common Stock
Jul 19 2023
SELL
Open market or private sale
$7,349 $0.08 p/Share
91,866 Reduced 66.44%
46,399 Common Stock
Jun 13 2022
BUY
Grant, award, or other acquisition
-
54,511 Added 28.28%
138,265 Common Stock
May 10 2022
BUY
Open market or private purchase
$100,016 $2.66 p/Share
37,600 Added 30.98%
83,754 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
26,395 Added 36.38%
46,154 Common Stock
Jun 14 2021
BUY
Grant, award, or other acquisition
-
19,759 Added 50.0%
19,759 Common Stock

Also insider at

ATRC
AtriCure, Inc. Healthcare
NVRO
NEVRO CORP Healthcare
EMBC
Embecta Corp. Healthcare
KP

Karen Prange

Director
Mason, OH

Track Institutional and Insider Activities on VRAY

Follow ViewRay, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRAY shares.

Notify only if

Insider Trading

Get notified when an View Ray, Inc. insider buys or sells VRAY shares.

Notify only if

News

Receive news related to ViewRay, Inc.

Track Activities on VRAY